These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 20214418)

  • 1. Innovation in biotechnology: moving from academic research to product development--the case of biosensors.
    Siontorou CG; Batzias FA
    Crit Rev Biotechnol; 2010 Jun; 30(2):79-98. PubMed ID: 20214418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A methodological combined framework for roadmapping biosensor research: a fault tree analysis approach within a strategic technology evaluation frame.
    Siontorou CG; Batzias FA
    Crit Rev Biotechnol; 2014 Mar; 34(1):31-55. PubMed ID: 23919240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biosensor technology: technology push versus market pull.
    Luong JH; Male KB; Glennon JD
    Biotechnol Adv; 2008; 26(5):492-500. PubMed ID: 18577442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The changing environment for technological innovation in health care.
    Goodman CS; Gelijns AC
    Baxter Health Policy Rev; 1996; 2():267-315. PubMed ID: 11066263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strategic alliances and market risk.
    Havenaar M; Hiscocks P
    Drug Discov Today; 2012 Aug; 17(15-16):824-7. PubMed ID: 22484547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The development of China's medical biotech industry needs to be driven by innovation.
    Yu Z; Dai Y
    Biotechnol J; 2006 Nov; 1(11):1253-7. PubMed ID: 17068752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Innovation in industry and the diffusion of technology.
    Utterback JM
    Science; 1974 Feb; 183(4125):620-6. PubMed ID: 17778831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Designing Genopole, a new concept and actor for science, technology and innovation policy in France].
    Branciard A
    Med Sci (Paris); 2009 May; 25 Spec No 2():9-12. PubMed ID: 19852085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enabling Europe to innovate.
    Dearing A
    Science; 2007 Jan; 315(5810):344-7. PubMed ID: 17234939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The attitudes of religious, environmental, and science policy leaders toward biotechnology.
    Miller JD
    Recomb DNA Tech Bull; 1985 Dec; 8(4):141-64. PubMed ID: 4095277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergy between Competitive Intelligence (CI), Knowledge Management (KM) and Technological Foresight (TF) as a strategic model of prospecting--the use of biotechnology in the development of drugs against breast cancer.
    Canongia C
    Biotechnol Adv; 2007; 25(1):57-74. PubMed ID: 17156964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adventurism in biomedical science: Washington University-Monsanto program in biotechnology.
    Gordon JI
    Pharos Alpha Omega Alpha Honor Med Soc; 1992; 55(2):31-5. PubMed ID: 1603830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From maturity to value-added innovation: lessons from the pharmaceutical and agro-biotechnology industries.
    Mittra J; Tait J; Wield D
    Trends Biotechnol; 2011 Mar; 29(3):105-9. PubMed ID: 21163543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Technology transfer at the University of Nebraska Medical Center.
    Matsuo K; Runge HJ; Miller DJ; Barak-Bernhagen MA; Boedeker BH
    Stud Health Technol Inform; 2011; 163():351-3. PubMed ID: 21335817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Applying the marketing mix (5 ps) to bionanotechnology.
    Tomczyk MS
    Methods Mol Biol; 2011; 726():393-411. PubMed ID: 21424463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The biotechnology innovation machine: a source of intelligent biopharmaceuticals for the pharma industry--mapping biotechnology's success.
    Evens RP; Kaitin KI
    Clin Pharmacol Ther; 2014 May; 95(5):528-32. PubMed ID: 24448474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. National Workshop on Astrobiology: the life science involvement of AAS-I Laben.
    Adami G
    Orig Life Evol Biosph; 2006 Dec; 36(5-6):567-76. PubMed ID: 17171428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of biotechnology products in the global pharmaceutical market: the case of the European community and the United States.
    Hakim Z; Kucukarslan S
    Clin Ther; 1993; 15(2):442-58; discussion 432. PubMed ID: 8519050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparing a business justification for going electronic.
    Ortiz AO; Luyckx MP
    Radiol Manage; 2002; 24(1):14-21. PubMed ID: 11857990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.